NCT02740283Unknown不适用
The Early Diagnosis of Gestational Diabetes Mellitus Study
First Affiliated Hospital, Sun Yat-Sen University0 个研究点目标入组 300 人开始时间: 2016年5月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 主要终点
- Rate of GDM diagnosed in 18-20 gestational week.
研究概览
简要总结
The main purpose of the study is to evaluate an OGTT at 18 to 20 gestational weeks as an early diagnosis method of GDM in low risk pregnant women. By investigating maternal and neonatal outcomes that are associated with the early OGTT and regular OGTT results, the study will provide a evidence for the most appropriate time to perform an OGTT in pregnant women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Singleton pregnant women will be invited to participate in this study if they are between 18 and 40 years of age, and have had their first prenatal visit in our center before 18 weeks 0 days of gestation.
排除标准
- •Previous history of GDM or preexisting DM
- •Family history of diabetes mellitus (first degree relative with diabetes or a sister with GDM)
- •Body mass index>30 kg/m2
- •Previous macrosomia (baby with birth weight >4,000 g) or a history of stillbirth
- •Polycystic ovary syndrome
- •Medications: corticosteroids, antipsychotics
- •Participant not willing to take OGTT twice (at 18-20 gestational weeks and 24-28 gestational weeks), or not willing to have a series of prenatal care visits and deliver in our center.
结局指标
主要结局
Rate of GDM diagnosed in 18-20 gestational week.
时间窗: up to 12 months
次要结局
未报告次要终点
研究者
Bin Liu
Dr.
First Affiliated Hospital, Sun Yat-Sen University
相似试验
终止
2 期
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)GliosarcomaGlioblastoma MultiformeNCT01186406Duke University41
已完成
1 期
GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)Diabetes Mellitus, Type 1NCT02352974Johnny Ludvigsson12
招募中
1 期
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesCutaneous MelanomaNon-Small Cell Lung CancerNCT05669430GV20 Therapeutics268
终止
1 期
A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerGastric CarcinomaGastroesophageal Junction CarcinomaClassical Hodgkin LymphomaDiffuse Large B-cell LymphomaPeripheral T-cell LymphomaHead and Neck Squamous Cell CarcinomaTriple Negative Breast CancerOvarian CancerCervical CancerBladder CancerNon-small Cell Lung CancerCutaneous MelanomaNCT04254107Seagen Inc.133
终止
1 期
Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.Non Small Cell Lung CancerNCT02335944Novartis Pharmaceuticals177